Robert A. Shalwitz
Oprichter bij Invirsa, Inc.
Oorsprong van het eerstegraads netwerk van Robert A. Shalwitz
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 27 | |
Invirsa, Inc.
 Invirsa, Inc. Medical/Nursing ServicesHealth Services Invirsa, Inc. provides medical services. The company was founded by Robert Shalwitz on November 24, 2014 and is headquartered in Bexley, OH.
4
| Holding Company | Medical/Nursing Services | 4 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Robert A. Shalwitz via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| MERIDIAN BIOSCIENCE, INC. | Miscellaneous Commercial Services | Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| KERYX BIOPHARMACEUTICALS | Pharmaceuticals: Major | Director of Finance/CFO Chairman President | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director of Finance/CFO Corporate Officer/Principal Comptroller/Controller/Auditor General Counsel Human Resources Officer | |
CS-Keys, Inc.
 CS-Keys, Inc. Medical SpecialtiesHealth Technology CS-Keys is the leader in discovery and development of cancer diagnostics based on the science of the DNA Synthesome. As the greatest potential for reducing mortality of cancer lies in the detection of asymptomatic, early stage disease, as well as for residual disease after treatment, the discovery of new markers for this purpose holds significant promise. CS-Keys patented caPCNA antibody may be a powerful ally in helping pathologists achieve this objective. CS-Keys, Inc. is a private, Indianapolis-based biotechnology company focused on the discovery and development of 3rd generation cancer-associated biomarkers using proteomics. These biomarkers may be used to create products to enhance the diagnosis and treatment of patients with cancer. CS-Keys was founded in early 2006 to develop and commercialize products based on the founders research and licensed from Indiana University. | Medical Specialties | President | |
Base4 Biotechnology, Inc.
 Base4 Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Nymirum, Inc. is a biotechnology company that aims to unlock the potential of RNA with small molecules to advance transformative medicine. The company is based in Ann Arbor, MI. The company's subsidiary, Base4 Biotechnology, is developing RNA-modulating small molecule drugs using their next-generation structure-based RNA platform. Nymirum was founded in 2009 by Mike E. Pape, Joshua Paul Fairbank, Hashim M. Al-Hashimi, and Andrew C. Stelzer. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
| AURA BIOSCIENCES, INC. | Biotechnology | Director of Finance/CFO Chief Operating Officer | |
| ANNEXON, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Aerpio Therapeutics, Inc.
 Aerpio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerpio Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases. The firm develops small molecules and monoclonal antibodies for the treatment of vascular disease and enhancement of wound healing. Its two lead programs include a tie-2 activator for diabetic macular edema and vascular leak, and a hypoxia-inducible factor 1-a stabilizer for wound healing and the treatment of inflammatory bowel disease. The company was founded by Joseph H. Gardner and Robert Shalwitz in 2011 and is headquartered in Cincinnati, OH. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Chairman Director/Board Member Founder Director/Board Member Director/Board Member Corporate Officer/Principal | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal | |
| Connecticut College | College/University | Undergraduate Degree | |
| Suffolk University | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin | |
| Massachusetts College of Liberal Arts | College/University | Undergraduate Degree Undergraduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree | |
The Ohio University
 The Ohio University Other Consumer ServicesConsumer Services Central Hockey League operates a professional minor league hockey teams playing in small to medium-sized markets primarily in central and southwestern US states. The league, which was started in 1992, is managed and operated by WPHL, a subsidiary of Global Entertainment Corporation. | College/University | Graduate Degree Graduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
| Utah State University | College/University | Graduate Degree | |
| University of Michigan | College/University | Undergraduate Degree Undergraduate Degree | |
Orchard Venture Partners
 Orchard Venture Partners Investment ManagersFinance Orchard Venture Partners (Orchard Venture Partners) is a venture capital subsidiary of Orchard Capital Management LLC founded in 2004. The firm is headquartered in Illinois. | Investment Managers | President Founder | |
Spring Mill Venture Partners
 Spring Mill Venture Partners Investment ManagersFinance Spring Mill Venture Partners (Spring Mill) is a venture capital firm founded in 2004 by Ken Green, Jane H. Martin and David O. Mann. The firm is headquartered in Carmel, Indiana. | Investment Managers | Consultant / Advisor | |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Human Resources Officer | |
BioOhio
 BioOhio Miscellaneous Commercial ServicesCommercial Services BioOhio is a non-profit organization that connects and serves Ohio's bioscience community to drive success in improving the quality of life. The non-profit company is based in Columbus, OH. With over 300 member organizations that employ over 100,000 people, BioOhio provides member-guided services that include networking, advocacy, events, talent, information, and cost savings. BioOhio is the state affiliate for bioscience associations such as Advamed, Bio, PhRMA, and more. Eddie Pauline has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
CincyTech LLC
 CincyTech LLC Investment ManagersFinance CincyTech LLC (CincyTech) is a venture capital firm founded in 2007. The firm is headquartered in Cincinnati, Ohio. | Investment Managers | Private Equity Investor | |
| MERUS N.V. | Biotechnology | Director/Board Member Director/Board Member | |
Novo Ventures 1 A/S
 Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures (Novo Ventures) is a venture capital operating division of Novo Nordisk Fonden. It engages in investment activities. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Investment Managers | Private Equity Investor Private Equity Investor | |
Global Cardiovascular Innovation Center
 Global Cardiovascular Innovation Center BiotechnologyHealth Technology Global Cardiovascular Innovation Center operates as a cardiovascular research and product development consortium. It focuses on the formation, attraction, expansion and retention of cardiovascular companies to create jobs and facilitate economic development in the State of Ohio. The company was founded in 2007 and is headquartered in Cleveland, OH. | Biotechnology | Director/Board Member | |
Rev1 Ventures
 Rev1 Ventures Investment ManagersFinance Rev1 Ventures (Rev1 Ventures) is a venture capital firm founded in 2003. The firm is headquartered in Columbus, Ohio. | Investment Managers | Private Equity Investor | |
Novartis Venture Funds (USA)
 Novartis Venture Funds (USA) Investment ManagersFinance Founded in 1996, Novartis Venture Funds (USA) is a venture capital firm located in Cambridge, Massachusetts. The firm is a subsidiary of Switzerland-based Novartis Venture Funds and their ultimate parent is Novartis AG, a Switzerland-based company that engages in the research, development, manufacturing and marketing of healthcare products. Novartis Venture Funds manages the Bermuda domiciled biotechnology venture fund, Novartis BioVentures Ltd | Investment Managers | Private Equity Investor Private Equity Investor | |
Airway Therapeutics, Inc.
 Airway Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Airway Therapeutics, Inc. operates as a pharmaceutical company which specializes in the development of surfactant-related products. The firm offers products for the prevention of bronchopulmonary dysplasia, as well as for the treatment of pulmonary infections associated with cystic fibrosis. It also provides pediatric drug development, orphan drug development, pulmonary therapies, protein drug development, neonatal drug therapy, and inhalation drug delivery. The company was founded by Charles McOsker in 2011 and is headquartered in Cincinnati, OH. | Pharmaceuticals: Major | Chairman | |
| The University of Chicago Booth School of Business | College/University | Masters Business Admin Masters Business Admin | |
Enable Injections, Inc.
 Enable Injections, Inc. Medical SpecialtiesHealth Technology Enable Injections, Inc. develops wearable bolus injectors for investigational use in the pharmaceutical and biotechnology industries to deliver high viscosity, high volume payloads up to 20cc to the subcutaneous tissue. The company was founded by Michael D. Hooven in February 2010 and is headquartered in Cincinnati, OH. | Medical Specialties | Director/Board Member | |
| Berlex Laboratories, Inc. | General Counsel | ||
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Anokion SA
 Anokion SA Medical/Nursing ServicesHealth Services Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland. | Medical/Nursing Services | Director/Board Member Chairman | |
Eccrine Systems, Inc.
 Eccrine Systems, Inc. Electronic Equipment/InstrumentsElectronic Technology Eccrine Systems, Inc. develops sweat sensor technologies. It is developing non-invasive, disposable, electronic patches that measure and transmit real-time data about human sweat. The company was founded by Robert Beech and Jason Heikenfeld on November 25, 2013 and is headquartered in Cincinnati, OH. | Electronic Equipment/Instruments | Director/Board Member | |
Kanyos Bio, Inc.
 Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Genetesis, Inc.
 Genetesis, Inc. Packaged SoftwareTechnology Services Genetesis, Inc. provides medical devices. Its technology utilizes the body’s weak magnetic fields to reconstruct, computationally, areas of high and low electrical conductivity in the heart. The firm also offers computational medicine, electrophysiology and diagnostics services. The company was founded by Peeyush Shrivastava in 2013 and is headquartered in Cincinnati, OH. | Packaged Software | Chairman | |
Xact Medical, Inc.
 Xact Medical, Inc. Medical SpecialtiesHealth Technology Xact Medical LLC develops medical devices. The firm develops Fast Intelligent Needle Delivery (FIND) system which will give clinicians a device to more precisely, quickly and conveniently place an object such as a needle tip in the body, reducing uncomfortable and time consuming trial and error. The company was founded in September 2016 and is headquartered in Cincinnati, OH. | Medical Specialties | Director/Board Member | |
| TSCAN THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
Kurome Therapeutics, Inc.
 Kurome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kurome Therapeutics, Inc. develops therapies that target cancer cells. The company was founded by Daniel Starczynowski and is headquartered in Cincinnati, OH. | Pharmaceuticals: Major | Chairman |
Statistieken
Internationaal
| Verenigde Staten | 45 |
| Denemarken | 4 |
| Nederland | 2 |
| Ierland | 2 |
| Zwitserland | 2 |
Sectoraal
| Health Technology | 26 |
| Consumer Services | 11 |
| Finance | 9 |
| Commercial Services | 4 |
| Health Services | 2 |
Operationeel
| Director/Board Member | 175 |
| Corporate Officer/Principal | 76 |
| Independent Dir/Board Member | 48 |
| Chairman | 42 |
| Director of Finance/CFO | 28 |
Sterkste connecties
| Insiders | |
|---|---|
| Jack Nielsen | 38 |
| Muneer Satter | 35 |
| Michael Wyzga | 31 |
| John M. Rice | 27 |
| Ronald Renaud | 24 |
| Maxine Gowen | 23 |
| Campbell Murray | 23 |
| Anupam Dalal | 18 |
| Giovanni A. Ferrara | 15 |
| William F. Daly | 15 |
| Ian Howes | 14 |
| Michael Clayman | 13 |
| Duane Nash | 13 |
| Mike E. Pape | 13 |
| John Butler | 12 |
- Beurs
- Insiders
- Robert A. Shalwitz
- Bedrijfsconnecties